Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
Lung Cancer (Amsterdam, Netherlands)|June 27, 2020
Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry DatabaseKeigo Kobayashi, Kenzo Soejima, Koichi Fukunaga, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 27, 2007
Multidetector-row computed tomography management of acute pulmonary embolismTakahiro Yasui, Nobuhiro Tanabe, Jiro Terada, et al.
Cancer Science|March 26, 2011
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesotheliomaAtsushi Kitamura, Kazuyuki Matsushita, Yuichi Takiguchi, et al.
Molecular and Clinical Oncology|September 3, 2019
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017Yoshiro Nakahara, Yukio Hosomi, Masahiko Shibuya, et al.
Clinical Lung Cancer|June 5, 2018
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study ProtocolYoshihito Kogure, Hideo Saka, Yuichi Takiguchi, et al.
Cancer Medicine|December 15, 2020
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancerTsuneo Shimokawa, Kazuhiko Yamada, Hiroshi Tanaka, et al.
Plos One|August 8, 2013
Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cellsTomoko Saito, Tetsuhiro Chiba, Kaori Yuki, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 22, 2012
CD40 amplifies Fas-mediated apoptosis: a mechanism contributing to emphysemaAyako Shigeta, Yuji Tada, Ji-Yang Wang, et al.
Cancer|December 6, 2017
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)Nobuyuki Katakami, Junji Uchino, Takuma Yokoyama, et al.
Head & Neck|September 18, 2010
Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cellsYukio Yamano, Masashi Shiiba, Kenji Negoro, et al.
Pageof 22